Dr. Taeyoung Shin was born in the Republic of Korea, earned a DVM, then continued his studies for a MS and a Ph.D in Veterinary Theriogenology at the College of Veterinary Medicine, Seoul National University. Dr. Shin’s major interest is assisted reproductive technology, especially in animal cloning. He then decided to join Drs. Mark Westhusin and Dr. Kraemer’s group in order to clone a dog, known as the Missyplicity project, which was not accomplished at that time. During his work at Texas A&M as a research scientist, he focused on producing a variety of cloned domestic and companion animal species such as cattle, pigs sheep, goats, dogs, horses, the world’s first cat and white tailed deer for over 7 years. The experience gained in cloning attempts of several species throughout the course of this work proposes a challenge to those not yet encountered. After the success in animal cloning, he decided to leave the academia and devote his talent in the industrial field. He joined Genetic Savings & Clone and worked for ViaGen as the Director of Reproductive Technology in livestock species. In 2008, he continues his endeavor in companion animal cloning through international collaboration and the management of a Beijing Lab in BioArts as the VP of Research & Development. Currently, he is implementing new research using cutting edge technologies such as the microfluidics device and non-invasive ova assessments using multi-photons in a continuous effort to solve the mysteries of cloning which are yet to be fully discovered.